MetLife Investment Advisors »

Compass Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $39k 21k 1.84
2024-06-30 $24k 24k 1.00
2023-12-31 $78k 50k 1.56
2023-09-30 $98k 50k 1.97
2023-06-30 $159k 50k 3.18